Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
Appointed director
CC transcript
Inv. presentation
Director comp.

Assertio Therapeutics, Inc (ASRT) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/16/2020 8-K/A Financial Statements and Exhibits
Docs: "Unaudited Pro Forma Financial Information of the Company"
08/17/2018 8-K/A Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Depomed Announces Second-Quarter 2018 Financial Results"
12/14/2017 8-K/A Financial Statements and Exhibits
Docs: "Waiver and Second Amendment to Note Purchase Agreement"
10/09/2013 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Consent of KPMG LLP",
"Lazanda Financial Statements",
"Unaudited Pro Forma Condensed Combined Balance Sheet and the notes related thereto"
10/17/2011 8-K/A Form 8-K - Current report [amend]
12/23/2002 8-K/A Financial statements and exhibits
12/23/2002 8-K/A Financial statements and exhibits

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy